LAUREN HINNANT: Open Payments
NPI 1326527482 · CORDELE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$651 in 38 payments from 12 companies in 2025. Trend: 2023 $659 · 2024 $905 · 2025 $651
Food & beverage: $651
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $158 |
| Novo Nordisk Inc | 5 | $114 |
| PFIZER INC. | 4 | $67 |
| Lilly USA, LLC | 3 | $66 |
| ABBVIE INC. | 4 | $62 |
| Amgen Inc. | 3 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Astellas Pharma US Inc | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 3 | $22 |
| Philips North America LLC | 1 | $20 |
Products named: TRELEGY ELLIPTA, Ozempic, VRAYLAR, Wegovy, MOUNJARO, PREVNAR 20, JARDIANCE, Veozah.
Industry payments across GA — which companies pay providers there.
